Drug giant GSK has struck a $20 million one-year deal to gain access to genetics information from 23andMe. The news comes just ahead of GSK’s latest financial report which is due Wednesday.
Read More
Kriya Therapeutics Inc., with dual headquarters in Durham and Palo Alto, Calif., has acquired a gene therapy startup that Kriya says will align with its approach to treating metabolic disease.
Read More
Editor’s note: Deep Dive – a feature looking in depth at timely issues from tech to jobs – is a regular feature weekly in TechWire. +++ RALEIGH – Researchers have genetically engineered a marine microorganism to break down plastic in salt water. Specifically, the modified organism can break down polyethylene terephthalate...
Read More
Global pharmaceutical firm Astellas, which operates a $100 million gene therapy manufacturing plant in Sanford, is investing $50 million in San Diego-based Poseida Therapeutics.
Read More
BioSkryb Genomics, a Durham developer of amplification tools for single-cell analysis, has signed an agreement with a Dutch company to expand distribution of BioSkryb’s genomic and multiomic technology in Europe. Here are the details.
Read More
North Carolina State University researchers have identified the specific blend of pheromone chemicals – including a newly revealed aphrodisiac – used by male moths during courtship as they attempt to entice females to mate. Check out their findings.
Read More
KaryoLogic, which is based in Durham, is teaming up with a French biotechnology company to test and analyze chromosomes in human stem cells. Here are the details.
Read More
Researchers have developed a “homing gene drive system” based on CRISPR/Cas9 that could be used to suppress populations of Drosophila suzukii vinegar flies – so-called “spotted-wing Drosophila” that devastate soft-skinned fruit in North America, Europe and parts of South America – according to new research from North Carolina State University.
Read More
Gene sequencing test maker Illumina Inc. said Sunday that its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately.
Read More
